Abstract
Objective
In the literature the frequency of splenic metastasis is documented very inconsistently. Only metastases of ovarial cancer are recommended for a surgical therapy. We examined the frequency of splenic metastasis in our hospital.
Method
The data of the Tumorboard Schwerin has been analyzed for splenic metastases. Based on hospital documents and contact via telephone the clinical course of the patients was also examined.
Results
A total of 6,137 of 29,364 patients with malignant tumors developed metastases (20.9%). We found 59 of these patients with splenic metastases (0.96%; 0.002% of all patients with malignant tumors). Men were more frequently concerned then women. The median age of the patients was 62 (26–88) years. There are only a few primary tumors metastasized in more than 1% into the spleen. A total of 47% of these metastases were synchronous, 53% metachronous. Only three patients had isolated splenic metastasis. Two further patients also had lymph node metastasis in the splenic hilus. Two other patients developed liver metastases after splenectomy. We performed four splenectomies because of splenic metastasis. The survival of splenic metastasis was median 3 (0–61) months.
Discussion
The published studies of the frequency of the splenic metastasis are autopsy studies, which are not usable for epidemiological statements because of selection bias. We show that splenic metastases arise in less than 1% of all metastases. A splenectomy in case of splenic metastases makes sense, if the metastases are isolated. It is also meaningful as a debulking procedure that would be followed by a chemotherapy, e.g. in case of an ovarial carcinoma. As a result the survival is increased for patients undergoing splenectomy (median survival 19.5 vs. 3 months).
Similar content being viewed by others
References
Berge T (1974) Splenic metastasis. Frequencies and patterns. Acta Path Microbiol Scand 82:499–506
Brunschwieg A, Morton DR (1946) Resection of abdominal carcinomas involving the liver and spleen secondarily. Ann Surg 124:746–754
Coman DR, DeLong RP, McCutcheon M (1951) Studies on the mechanism of metastasis; the distribution of tumors in various organs in relation to the distribution of arteria emboli. Cancer Res 11:648–651
Harman JW, Dacorso P (1948) Spread of carcinoma to the spleen. Arch Pathol 45:179–186
Hirst AE, Bullock WK (1952) Metastatic carcinoma of the spleen. Am J Med Sci 223:414–417
Lee SS, Morgenstern L, Phillips EH, Hiatt JR, Margulies DR (2000) Splenectomy for splenic metastases: a changing clinical spectrum. Am Surg 66:837–840
McClure JN, Park YH (1975) Solitary metastatic carcinoma of the spleen. South Med J 68:101–104
Nicklin JL, Copeland LJ, O’Toole RV, Lewandowski GS, Vaccarello L, Havenar LP (1995) Splenectomy as part of cytoreductive surgery for ovarian cancer. Gynecol Oncol 58:244–247
Shaw Dunn RI (1955) Cancer metastasis in the spleen. Glasg Med J 36:43–49
Teears RJ, Batsakis JG, Weatherbee L (1976) Unusual metastasis from an anaplastic carcinoma in the parotid gland. J Oral Surg 34:551–552
Warren S, Davis AH (1934) Studies on tumor metastasis: the metastases of carcinoma to the spleen. Am J Cancer 21:517–533
Watson GF, Diller IC, Ludwick NW (1947) Spleen extract and tumor growth. Science 106:348
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sauer, J., Sobolewski, K. & Dommisch, K. Splenic metastases—not a frequent problem, but an underestimate location of metastases: epidemiology and course. J Cancer Res Clin Oncol 135, 667–671 (2009). https://doi.org/10.1007/s00432-008-0502-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-008-0502-3